Safety and immunogenicity of the third and fourth doses of vaccine against SARS-CoV-2 following a 2-dose regimen of inactivated whole-virion SARS-CoV-2 vaccine
在完成两剂灭活全病毒SARS-CoV-2疫苗接种方案后，第三剂和第四剂SARS-CoV-2疫苗的安全性和免疫原性
期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-023-45735-7
Chaiwarith, Romanee; Winichakoon, Poramed; Salee, Parichat; Sudjaritruk, Tavitiya; Wipasa, Jiraprapa; Chawansuntati, Kriangkrai; Yasri, Saowaluck; Thongwitokomarn, Harit; Krasaewes, Kawisara; Ruangsirinusorn, Sethawut; Praparattanapan, Jutarat; Solai, Nuttarika; Nuket, Khanuengnit; Boonmee, Darakorn; Chaichana, Orapin; Mueangmo, Oramai; Saheng, Jutamad; Wongjak, Worawan
